Enanta Pharmaceuticals Partner
Enanta Pharmaceuticals is a clinical-stage biotechnology company based in Watertown, Massachusetts. Founded in 1995, the company focuses on discovering and developing small molecule therapeutics for viral and immune-mediated diseases. With a team of approximately 125 employees, Enanta has a market capitalization of around $280 million.
The company specializes in innovative chemistry to create differentiated drugs, particularly in the area of protease and core protein inhibitors. Enanta has made significant contributions to the treatment of Hepatitis C, with therapies that have led to over one million cures worldwide, including the protease inhibitor glecaprevir. Their pipeline includes promising candidates for Hepatitis B, Respiratory Syncytial Virus, and COVID-19. Enanta collaborates with notable partners like AbbVie and Novartis to enhance its drug development efforts and advance clinical trials. The company is dedicated to addressing global health challenges through its targeted drug development initiatives.
